OTX crowned its junior middleweight tournament winner as Andreas Katzourakis edged Brandon Adams by split decision in ...

The OTX junior middleweight tournament will conclude on Friday after Brandon Adams and Andreas Katzourakis both weighed in at ...

The market for Medinex Limited's ( Catalist:OTX ) shares didn't move much after it posted weak earnings recently.

If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? When ...

Omega Therapeutics is halting work on its only clinical-stage candidate as part of a strategic refocus centered on three ...

Return on Assets (ROA): Ocular Therapeutix's ROA falls below industry averages, indicating challenges in efficiently ...

The Phase 1 monotherapy dose escalation portion of MYCHELANGELO I was designed to evaluate the safety, tolerability, pharmacokinetics, ...

AXPAXLI™ (axitinib intravitreal implant, also known as OTX-TKI), Ocular’s product candidate for retinal disease, is based on ...

Analyst Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Ocular Therapeutix (OCUL – Research Report) and increased ...

AXPAXLI™ (axitinib intravitreal implant, also known as OTX-TKI), Ocular's product candidate for retinal disease, is based on ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...